Pulse Biosciences (PLSE) Enterprise Value (2015 - 2025)

Pulse Biosciences' Enterprise Value history runs 11 years deep, the most recent figure standing at -$80.7 million for Q4 2025.

• On a quarterly basis, Enterprise Value rose 31.63% year-over-year to -$80.7 million in Q4 2025; TTM through Dec 2025 was -$80.7 million, a 31.63% increase from a year earlier, with the FY2025 full-year figure at -$80.7 million, up 31.63% from the prior year.
• Enterprise Value improved to -$80.7 million in Q4 2025 per PLSE's latest filing, from -$95.2 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$12.7 million in Q1 2022 and bottomed at -$119.3 million in Q1 2025.
• The 5-year median for Enterprise Value is -$55.2 million (2023), against an average of -$60.7 million.
• Across the five-year window, Enterprise Value tumbled 453.73% in 2021 and surged 78.83% in 2022, its largest moves.
• Year by year, Enterprise Value stood at -$44.4 million in 2021, then sank by 30.67% to -$58.0 million in 2022, then rose by 23.47% to -$44.4 million in 2023, then tumbled by 166.06% to -$118.0 million in 2024, then soared by 31.63% to -$80.7 million in 2025.
• Per Business Quant, the three latest PLSE Enterprise Value figures stand at -$80.7 million (Q4 2025), -$95.2 million (Q3 2025), and -$106.3 million (Q2 2025).